Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$192M |
| 2 |
Johnson & Johnson
JNJ
|
+$179M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$177M |
| 4 |
Chubb
CB
|
+$153M |
| 5 |
Eli Lilly
LLY
|
+$142M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$470M |
| 2 |
PRE
PARTNERRE LTD
PRE
|
+$186M |
| 3 |
Comcast
CMCSA
|
+$179M |
| 4 |
Pfizer
PFE
|
+$168M |
| 5 |
Gilead Sciences
GILD
|
+$144M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 11.92% |
| 2 | Healthcare | 11.63% |
| 3 | Technology | 11.35% |
| 4 | Industrials | 10.55% |
| 5 | Consumer Staples | 10.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PACD
2901
DELISTED
Pacific Drilling S A
PACD
| $405K | ﹤0.01% |
82,630
+40,590
| +97% | +$195K |
|
2902
Full House Resorts
FLL
$83.5M
| $404K | ﹤0.01% |
280,300
+11,600
| +4% | +$17K |
|
2903
MediWound
MDWD
$179M
| $402K | ﹤0.01% |
7,114
+1,157
| +19% | +$60.5K |
|
|
STV
2904
DELISTED
China Digital Tv Hldgs Co Ltd
STV
| $402K | ﹤0.01% |
266,009
-44,587
| -14% | -$60.1K |
|
2905
Electromed
ELMD
$352M
| $401K | ﹤0.01% |
+96,600
| New | +$300K |
|
2906
Fate Therapeutics
FATE
$294M
| $401K | ﹤0.01% |
222,700
+134,200
| +152% | +$276K |
|
2907
Kingstone Companies
KINS
$284M
| $395K | ﹤0.01% |
47,800
+5,286
| +12% | +$42.3K |
|
|
ESI
2908
DELISTED
ITT EDUCATIONAL SERVICES INC
ESI
| $394K | ﹤0.01% |
127,600
+45,100
| +55% | +$131K |
|
|
MICR
2909
DELISTED
Micron Solutions, Inc.
MICR
| $393K | ﹤0.01% |
92,500
+1,500
| +2% | +$6.73K |
|
|
SYUT
2910
DELISTED
Synutra International, Inc.
SYUT
| $393K | ﹤0.01% |
79,000
-33,100
| -30% | -$161K |
|
2911
ITT
ITT
$19.4B
| $391K | ﹤0.01% |
+10,600
| New | +$361K |
|
2912
MacroGenics
MGNX
$259M
| $389K | ﹤0.01% |
20,723
-71,941
| -78% | -$1.37M |
|
2913
ImmuCell
ICCC
$99.3M
| $388K | ﹤0.01% |
56,707
+8,907
| +19% | +$59.4K |
|
2914
HEICO Corp
HEI
$52.1B
| $385K | ﹤0.01% |
15,625
-271,580
| -95% | -$6.24M |
|
|
LCI
2915
DELISTED
Lannett Company, Inc.
LCI
| $385K | ﹤0.01% |
+5,375
| New | +$569K |
|
|
SOHO
2916
DELISTED
Sotherly Hotels
SOHO
| $384K | ﹤0.01% |
74,700
-40,700
| -35% | -$219K |
|
|
PQUE
2917
DELISTED
PETROQUEST ENERGY INC (DE)
PQUE
| $382K | ﹤0.01% |
629,654
+10,595
| +2% | +$6.43K |
|
2918
First US Bancshares
FUSB
$90.6M
| $381K | ﹤0.01% |
47,000
+7,800
| +20% | +$65.7K |
|
2919
Northern Oil and Gas
NOG
$2.57B
| $380K | ﹤0.01% |
+9,535
| New | +$325K |
|
|
RBS.PRF.CL
2920
DELISTED
Royal Bk Of Scotland Gp
RBS.PRF.CL
| $380K | ﹤0.01% |
14,800
-13,700
| -48% | -$349K |
|
|
HBP
2921
DELISTED
Huttig Building Products, Inc.
HBP
| $378K | ﹤0.01% |
102,800
+47,500
| +86% | +$162K |
|
|
GNMK
2922
DELISTED
GenMark Diagnostics, Inc
GNMK
| $376K | ﹤0.01% |
+71,300
| New | +$397K |
|
|
PSIX
2923
Power Solutions International
PSIX
$947M
| $372K | ﹤0.01% |
+26,946
| New | +$321K |
|
|
DDE
2924
DELISTED
Dover Downs Gaming & Entertain
DDE
| $370K | ﹤0.01% |
346,200
+13,200
| +4% | +$13.4K |
|
2925
Clarus
CLAR
$141M
| $369K | ﹤0.01% |
82,063
+40,077
| +95% | +$175K |
|
Similar funds
Jim Simons's Q1 2016 Portfolio in Review
As of Q1 2016, Jim Simons held 3,753 positions worth $52.6B, up 15% from $45.9B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.31B of net new capital in Q1 2016, opening 498 new positions and adding to 2,018 existing holdings. Its largest new stake was EMC CORPORATION: 7,000,400 shares worth $187M.
By sector, the portfolio is most concentrated in Financials at 12% of assets, up from 11% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Pfizer, an estimated $168M trimmed.
- Jim Simons's largest Q1 2016 buy was EMC CORPORATION: 7,000,400 shares worth $187M.
- Jim Simons added most to PepsiCo in Q1 2016, an estimated $192M increase.
- Jim Simons's biggest Q1 2016 reduction was Pfizer, cutting an estimated $168M.
- Jim Simons fully exited Apple in Q1 2016, selling an estimated $470M.
- Jim Simons's ten largest holdings make up 7.9% of its $52.6B portfolio in Q1 2016.
- Jim Simons opened 498 new positions and closed 403 in Q1 2016.
- Jim Simons's portfolio value rose 15% quarter-over-quarter to $52.6B.
Based on Renaissance Technologies's 13F filing for Q1 2016, filed 13 May 2016.